CFDI's Global Drug Inspection Trend Study Offers Regulatory Updates and Opinions
By Yingying Liu, Siegfried Schmitt -
Published 15 February 2017
To help keep regulatory professionals up-to-date on current thinking by global regulatory agencies, the Chinese Center of Food and Drug Inspection (CFDI) released a new electronic journal covering hot topics and developments in international drug manufacturing inspections. This article summarizes the key points including regulatory thinking and opinions from global regulatory authorities and organizations; timely updates on regulations, guidance, regulatory measures and changes; and inspection case analysis through observations by various international regulatory authorities.
Categories: Features, China, CFDA, FDA, WHO, Government affairs, Regulatory intelligence
Tags: Chinese Center of Food and Drug Inspection, CFDI